Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | 150,672 | N/A |
| Depreciation Amortization | N/A | N/A | N/A | 18,943 | N/A |
| Accounts receivable | N/A | N/A | N/A | -6,778 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -3,652 | N/A |
| Other Working Capital | N/A | N/A | N/A | -104,118 | N/A |
| Other Operating Activity | -38,090 | -16,661 | -21,691 | -163,508 | -77,079 |
| Operating Cash Flow | $-38,090 | $-16,661 | $-21,691 | $-108,441 | $-77,079 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 53,845 | -23,890 | 33,023 | -197,495 | -185,998 |
| PPE Investments | -12,740 | -11,894 | -11,009 | -13,414 | -11,662 |
| Net Acquisitions | 10,147 | 10,147 | 10,147 | N/A | N/A |
| Purchase Of Investment | -658 | -658 | -459 | -1,349 | -349 |
| Sale Of Investment | N/A | N/A | N/A | 2,848 | 2,848 |
| Purchase Sale Intangibles | -3,430 | -2,455 | -516 | -2,880 | -1,915 |
| Other Investing Activity | -19,658 | -18,683 | -16,744 | -2,880 | -1,915 |
| Investing Cash Flow | $30,936 | $-44,978 | $14,958 | $-212,290 | $-197,076 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 6,394 | N/A |
| Debt Repayment | -3,098 | -1,943 | -963 | -2,827 | -1,896 |
| Common Stock Issued | 2,036 | 1,282 | 1,031 | 198,156 | 194,795 |
| Other Financing Activity | 3,083 | 3,083 | 0 | 278 | 6,564 |
| Financing Cash Flow | $2,021 | $2,422 | $68 | $202,001 | $199,463 |
| Beginning Cash Position | 105,255 | 105,255 | 105,255 | 223,985 | 223,985 |
| End Cash Position | 100,122 | 46,038 | 98,590 | 105,255 | 149,293 |
| Net Cash Flow | $-5,133 | $-59,217 | $-6,665 | $-118,730 | $-74,692 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,090 | -16,661 | -21,691 | -108,441 | -77,079 |
| Capital Expenditure | -12,740 | -11,894 | -11,009 | -13,414 | -11,662 |
| Free Cash Flow | -50,830 | -28,555 | -32,700 | -121,855 | -88,741 |